- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | AZ's ADC receives priority review | ||
| Do | Glenmark spins out bispecific portfolio through Ichnos | ||
| Mi | Sanofi begins global digital-enhancement manufacturing project with US facility | ||
| Mi | BIA Separations adds to Cornerstone vector development program | ||
| Di | Microneedle-packed capsule enables oral insulin delivery | ||
| Di | Adaptimmune in 'vein-to-vein' deal with Cryoport's SmartPak | ||
| Di | Nine ingredients to promote biosimilar uptake | ||
| 10.10. | Novo Nordisk looks to bluebird for gene therapy targets | ||
| 10.10. | N4 Pharma develops spiky-surfaced silica nanoparticle delivery system | ||
| 10.10. | GSK adopts Lyell's services to improve T cell 'fitness' | ||
| 09.10. | AstraZeneca earns FDA nod for at-home autoinjector | ||
| 09.10. | Merck doubles down on live biotherapeutics with 4D deal | ||
| 09.10. | Novartis gets approval for quarterly dosing wet AMD treatment | ||
| 08.10. | Terumo launches automated fill-finish system for cell therapies | ||
| 08.10. | J&J completes €300m Irish expansion, adding 200 jobs | ||
| 08.10. | Hired and Retired: Jumping on gene therapy | ||
| 04.10. | Top five stories from September | ||
| 03.10. | Astellas provides funding for US cell and gene therapy biotechs | ||
| 03.10. | Lonza in deal to manufacture Cellectis' UCART oncology pipeline | ||
| 02.10. | US signs deal for second-line smallpox 'biodefense therapeutic' | ||
| 02.10. | Immunovant goes public after investment from HSAC | ||
| 02.10. | China and Russia collaborate to create biologics joint venture | ||
| 01.10. | Glenmark opts for Horizon's gene edited cell lines | ||
| 01.10. | CureDuchenne backs immune-resistant AAV gene therapy platform | ||
| 01.10. | FDA answer to low biosimilar uptake? Increased communication |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
